Fusion Pharmaceuticals Inc. (FUSN) Financials
FUSN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 253.4 million | 64.9 million |
2023-06-30 | 268.3 million | 65.3 million |
2023-03-31 | 266.6 million | 65.7 million |
2022-12-31 | 219.1 million | 56.8 million |
FUSN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -19.3 million | 3.0 million |
2023-06-30 | -20.3 million | 3.0 million |
2023-03-31 | -26.7 million | 3.1 million |
2022-12-31 | -20.3 million | 2.8 million |
FUSN Net Income
No data available :(
FUSN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 191.3 million | - | 18.0 million |
2023-06-30 | 198.1 million | - | 16.1 million |
2023-03-31 | 221.2 million | 34.4 million | 15.7 million |
2022-12-31 | 186.6 million | 34.2 million | 6.0 million |
FUSN Shares Outstanding
FUSN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 473000 | 14.6 million | 6.8 million | - |
2023-06-30 | 710000 | 19.0 million | 7.8 million | - |
2023-03-31 | 1.2 million | 15.9 million | 9.0 million | - |
2022-12-31 | 950000 | 17.6 million | 7.0 million | - |
FUSN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.0 million | 1.0 million |
2023-06-30 | 34000 | 931000 |
2023-03-31 | 28000 | 15.9 million |
2022-12-31 | 140000 | 17.6 million |
FUSN
Price: $21.45
52 week price:
Earnings Per Share: -1.45 USD
P/E Ratio: -6.94
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 14300
Market Capitalization: 1.8 billion